BioMarin Pharmaceutical, Inc. (BMRN)
56.34
-0.43
(-0.76%)
USD |
NASDAQ |
Jun 08, 15:36
BioMarin Pharmaceutical EPS Diluted (Quarterly) : 0.5431 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -0.5612 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Incyte Corp. | 1.467 |
| Mirum Pharmaceuticals, Inc. | -13.43 |
| Cytokinetics, Inc. | -1.671 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 105.53M |
| Revenue (Quarterly) | 778.62M |
| Total Expenses (Quarterly) | 673.09M |
| Enterprise Value | 10.20B |
| Gross Profit Margin (Quarterly) | 74.38% |
| Profit Margin (Quarterly) | 13.55% |
| Earnings Yield | 2.43% |
| Operating Earnings Yield | 6.71% |
| Normalized Earnings Yield | 4.868 |